Evidence map›Paper›PMID 34031660›Full record

ArticlemedRxiv : the preprint server for health sciences2021

Epidemiology and genetic diversity of SARS-CoV-2 lineages circulating in Africa.

Olayinka Sunday Okoh, Nicholas Israel Nii-Trebi, Abdulrokeeb Jakkari, Tosin Titus Olaniran, Tosin Yetunde Senbadejo, Anna Aba Kafintu-Kwashie, Emmanuel Oluwatobi Dairo, Tajudeen Oladunni Ganiyu, Ifiokakaninyene Ekpo Akaninyene, Louis Odinakaose Ezediuno and 6 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Olayinka Sunday Okoh *Department of Chemical Sciences, Anchor University, Lagos, Nigeria.
Nicholas Israel Nii-Trebi *Department of Medical Laboratory Sciences, School of Biomedical and Allied Health Sciences, University of Ghana, Accra, Ghana.
Abdulrokeeb JakkariDepartment of Microbiology, Faculty of Science, Lagos State University, Ojo, Lagos, Nigeria.
Tosin Titus OlaniranDepartment of Pure and Applied Biology (Microbiology Unit), Ladoke Akintola University of Technology, Ogbomoso, Nigeria.
Tosin Yetunde SenbadejoDepartment of Biological Sciences, College of Natural and Applied Sciences, Fountain University, Osogbo, Nigeria.
Anna Aba Kafintu-KwashieDepartment of Medical Microbiology Clinical Virology unit, University of Ghana Medical School, Accra, Ghana.
Emmanuel Oluwatobi DairoHelix Biogen Institute, Ogbomoso, Nigeria.
Tajudeen Oladunni GaniyuDepartment of Biological Sciences, College of Natural and Applied Sciences, Fountain University, Osogbo, Nigeria.
Ifiokakaninyene Ekpo AkaninyeneDepartment of Pure and Applied Biology (Microbiology Unit), Ladoke Akintola University of Technology, Ogbomoso, Nigeria.
Louis Odinakaose EzediunoDepartment of Microbiology, Faculty of life sciences, University of Ilorin, Nigeria.
Idowu Jesulayomi AdeosunDepartment of Microbiology, Laboratory of Molecular Biology, Immunology and Bioinformatics, Adeleke University, Ede, Osun State, Nigeria.
Michael Asebake OckiyaDepartment of Animal Science, Niger Delta University, Wilberforce Island, Bayelsa State, Nigeria.
Esther Moradeyo JimahHelix Biogen Institute, Ogbomoso, Nigeria.
David J SpiroFogarty International Center, National Institutes of Health, Bethesda, Maryland, USA.
Elijah Kolawole OladipoHelix Biogen Institute, Ogbomoso, Nigeria.
Nídia S TrovãoFogarty International Center, National Institutes of Health, Bethesda, Maryland, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 disease dynamics have been widely studied in different settings around the globe, but little is known about these patterns in the African continent. To investigate the epidemiology and genetic diversity of SARS-CoV-2 lineages circulating in Africa, more than 2400 complete genomes from 33 African countries were retrieved from the GISAID database and analyzed. We investigated their diversity using various clade and lineage nomenclature systems, reconstructed their evolutionary divergence and history using maximum likelihood inference methods, and studied the case and death trends in the continent. We also examined potential repeat patterns and motifs across the sequences. In this study, we show that after almost one year of the COVID-19 pandemic, only 143 out of the 782 Pango lineages found worldwide circulated in Africa, with five different lineages dominating in distinct periods of the pandemic. Analysis of the number of reported deaths in Africa also revealed large heterogeneity across the continent. Phylogenetic analysis revealed that African viruses cluster closely with those from all continents but more notably with viruses from Europe. However, the extent of viral diversity observed among African genomes is closest to that of the Oceania outbreak, most likely due to genomic under-surveillance in Africa. We also identified two motifs that could function as integrin-binding sites and N-glycosylation domains. These results shed light on the evolutionary dynamics of the circulating viral strains in Africa, elucidate the functions of protein motifs present in the genome sequences, and emphasize the need to expand genomic surveillance efforts in the continent to better understand the molecular, evolutionary, epidemiological, and spatiotemporal dynamics of the COVID-19 pandemic in Africa.

Identifiers

PMID34031660
PMCPMC8142660

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.